Inactive Instrument

Other languages Enzymatica AB Nasdaq Stockholm

Equities

SE0003943620

Other languages

Unlock all the news: Be the first to know and act before the market!

Enzymatica AB Announces Interim Results from Independent Clinical Study of Coldzyme® Show Duration of Illness Lowered by Approximately 5 Days	13/06
Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Enzymatica AB Announces Composition of Nomination Committee	28/03
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray	11/03
Enzymatica AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Enzymatica AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Enzymatica’s Oral Spray Trial Reduces Viral Load in Common Colds	21/23/21
Enzymatica AB Announces Interim Report from Clinical Study: ColdZyme Significantly Reduces Rhinovirus Viral Load and Symptoms of Sore Throat	21/23/21
Enzymatica AB Announces New Study	22/23/22
Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	18/23/18
Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27
Enzymatica AB Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17
Enzymatica AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	17/23/17
Enzymatica AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	02/22/02
Enzymatica Surges 35% After New Study Confirms ColdZyme Stops Omicron From Infecting Human Cells	01/22/01
Enzymatica Raises $7 Million Via Rights Issue	26/22/26
Enzymatica To Boost Financial Position Via $7 Million Rights Offering	19/22/19
Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	19/22/19
Enzymatica AB Announces New Data from an Ongoing In-Vitro Study	23/22/23
Enzymatica AB Appoints Moa Fransson as New Member of the Board	28/22/28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Enzymatica AB Nasdaq Stockholm

Equities

SE0003943620

Other languages

Filters